Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP synthase membrane subunit e is a small integral membrane protein component of the F₀ sector of mitochondrial (and yeast) ATP synthase (Complex V). Subunit e is anchored to the inner mitochondrial membrane via its N-terminal hydrophobic domain, while its C-terminus extends into the intermembrane space. It is essential for dimerization and oligomerization of ATP synthase, which are critical for maintaining cristae morphology and efficient ATP production. Disruption of subunit e leads to abnormal mitochondrial structure, impaired DNA maintenance, and defective bioenergetics. While inhibitors of ATP synthase affect the overall complex, no approved drugs act selectively on subunit e. Pathogenic mutations in subunit e can contribute to mitochondrial disease through destabilization of the ATP synthase dimer and loss of ATP production capacity.
Inhibition of ATP synthase activity (e.g., oligomycin binds F₀, prevents proton flow, inhibiting ATP production overall). Disruption or mutation of subunit e compromises ATP synthase dimerization and function, indirectly reducing ATP synthesis.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase membrane subunit e (Subunit e).